The IASLC 2026 Hot Topic in Basic and Translational Science Meeting is dedicated to one of the most formidable hurdles in thoracic oncology: Resistance to Immunotherapy. Taking place from June 26–27, 2026, at Trinity College Dublin, this focused summit brings together an elite cohort of scientists and clinicians to dissect the biological mechanisms behind primary and acquired resistance.

Chaired by experts including Patrick Forde (Trinity College Dublin) and Fabrizio Bianchi (IRCCS), the meeting will explore the complex interplay within the tumor microenvironment (TME) and the role of emerging biomarkers. By integrating cutting-edge discovery with clinical application, the conference serves as a critical collaborative engine for developing novel therapeutic strategies to achieve more durable outcomes for lung cancer patients worldwide.

Registration officially opens on March 6th.